| abstract |
REFERS TO A COMPOSITION THAT INCLUDES a) GROWTH FACTOR SUCH AS CHRYSALIN, VASCULAR ENDOTHELIUM GROWTH FACTOR (VEGF), EPIDERMAL GROWTH FACTOR (EGF), PLATELET-DERIVED GROWTH FACTOR (FACTOR FACTOR OF CREWFASTCI (PDGFASTCI), ), CONJUNCTIVE TISSUE DERIVED GROWTH FACTOR (CTGF), KERATOCYTE DERIVED GROWTH FACTOR (KGF), TRANSFORMATION GROWTH FACTOR (TGF), COLONIAL STIMULATING FACTOR (CSF), b) INHIBITOR INHIBITOR AGENT, PROHIBITOR INHIBITOR OF PLASMINOGEN TYPE UROQUINASE, INHIBITOR OF METALOPROTEASE; c) VEHICLE, THINNER. IT ALSO REFERS TO A PROCEDURE FOR PREPARATION. THE COMPOSITION IS CHARACTERIZED BECAUSE THE INHIBITOR OF SPECIFIC PROTEASES IS POSITIVELY REGULATED IN A WOUND OR THE COMBINATION OF THE INHIBITOR AND THE FACTOR PRODUCES A SYNERGIC EFFECT. THE COMPOSITION MAY BE USEFUL FOR THE TREATMENT OF DAMAGED TISSUE, CHRONIC WOUND, DERMAL ULCER |